Blockchain Registration Transaction Record

Izotropic Secures Exclusive US Patent for AI-Powered Breast Cancer Diagnosis Tech

Izotropic Corporation secures exclusive US patent for AI-powered breast cancer diagnosis technology using breast CT, revolutionizing early detection and diagnostic accuracy for improved patient outcomes.

This development matters because breast cancer affects approximately 1 in 8 women during their lifetime, making early and accurate detection critical for survival. Current screening methods have limitations in detecting certain types of cancers, particularly in women with dense breast tissue. Izotropic's AI-powered CADx technology with breast CT could significantly improve detection rates, reduce false positives, and streamline diagnostic workflows, ultimately leading to earlier interventions and better patient outcomes. For the healthcare system, this innovation could reduce costs associated with delayed diagnoses and unnecessary procedures while improving efficiency in radiology departments.